120 related articles for article (PubMed ID: 30684461)
1. p53 mediates hydroxyurea resistance in aneuploid cells of colon cancer.
Fang X; Yin H; Zhang H; Wu F; Liu Y; Fu Y; Yu D; Zong L
Exp Cell Res; 2019 Mar; 376(1):39-48. PubMed ID: 30684461
[TBL] [Abstract][Full Text] [Related]
2. Differences in telomerase activity and the effects of AZT in aneuploid and euploid cells in colon cancer.
Fang X; Hu T; Yin H; Yang J; Tang W; Hu S; Xu X
Int J Oncol; 2017 Aug; 51(2):525-532. PubMed ID: 28627647
[TBL] [Abstract][Full Text] [Related]
3. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
4. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
5. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Gong EY; Shin YJ; Hwang IY; Kim JH; Kim SM; Moon JH; Shin JS; Lee DH; Hur DY; Jin DH; Hong SW; Lee WK; Lee WJ
Toxicol Lett; 2016 Sep; 258():126-133. PubMed ID: 27339904
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.
Kadioglu O; Saeed M; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T
Arch Toxicol; 2021 Mar; 95(3):959-974. PubMed ID: 33515271
[TBL] [Abstract][Full Text] [Related]
8. P53 induces senescence in the unstable progeny of aneuploid cells.
Giam M; Wong CK; Low JS; Sinelli M; Dreesen O; Rancati G
Cell Cycle; 2020 Dec; 19(24):3508-3520. PubMed ID: 33305692
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 interferes with homeodomain-interacting protein kinase 2/p53 activity to impair solid tumors chemosensitivity.
D'Orazi G; Garufi A; Cirone M
IUBMB Life; 2020 Aug; 72(8):1634-1639. PubMed ID: 32593231
[TBL] [Abstract][Full Text] [Related]
10. Quinaldic acid induces changes in the expression of p53 tumor suppressor both on protein and gene level in colon cancer LS180 cells.
Langner E; Jeleniewicz W; Turski WA; Plech T
Pharmacol Rep; 2019 Apr; 71(2):189-193. PubMed ID: 30780127
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
12. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
Li J; Chen Y; Zhao J; Kong F; Zhang Y
Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
[TBL] [Abstract][Full Text] [Related]
13. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia.
Leitch C; Osdal T; Andresen V; Molland M; Kristiansen S; Nguyen XN; Bruserud Ø; Gjertsen BT; McCormack E
Oncotarget; 2016 Feb; 7(7):8105-18. PubMed ID: 26812881
[TBL] [Abstract][Full Text] [Related]
16. Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.
Liu C; Banister CE; Buckhaults PJ
Cancer Res; 2019 May; 79(9):2392-2403. PubMed ID: 30862715
[TBL] [Abstract][Full Text] [Related]
17. p14(ARF) Prevents Proliferation of Aneuploid Cells by Inducing p53-Dependent Apoptosis.
Veneziano L; Barra V; Lentini L; Spatafora S; Di Leonardo A
J Cell Physiol; 2016 Feb; 231(2):336-44. PubMed ID: 25752701
[TBL] [Abstract][Full Text] [Related]
18. Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny.
Wiedemuth R; Klink B; Fujiwara M; Schröck E; Tatsuka M; Schackert G; Temme A
Carcinogenesis; 2016 Oct; 37(10):993-1003. PubMed ID: 27515963
[TBL] [Abstract][Full Text] [Related]
19. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.
Liu RX; Ren WY; Ma Y; Liao YP; Wang H; Zhu JH; Jiang HT; Wu K; He BC; Sun WJ
Int J Oncol; 2017 Sep; 51(3):907-917. PubMed ID: 28731124
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]